MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Neural Signatures of Hallucination Emergence in Dementia with Lewy Bodies

    R. Vin, S. Moret, HY. Yi, M. Lawrence, V. Santini, J. Cedarbaum, A. Powers, C. Fredericks (New Haven, USA)

    Objective: REM sleep behavior disorder (RBD) is a prodromal state for alpha-synucleinopathy. Here, we present a behavioral marker for hallucination propensity that distinguishes Dementia with…
  • 2025 International Congress

    Predictors of Health-Related Quality of Life in Parkinson’s Disease: A Five-Year Longitudinal Study

    O. Zabala-Gómez, O. Lucas-Jiménez, B. Tijero, I. Gabilondo, J. Peña, N. Ojeda, L. Zubiaurre-Elorza, J. Diez-Huici, M. Acera, R. Del Pino, JC. Gómez-Esteban, N. Ibarretxe-Bilbao (Bilbao, Spain)

    Objective: The aim of this study was to identify the predictors for health-related quality of life (HRQoL) in Parkinson´s disease (PD) in a 5-year longitudinal…
  • 2025 International Congress

    Cognitive and Neuropsychiatric Dysfunction is Associated with Corticostriatal Synucleinopathy in the Alpha-Synuclein Preformed Fibril Rat Model of Parkinson’s Disease

    J. Bechtold, J. Patterson, C. Kemp, A. Stoll, S. Arrington, M. Venard, L. Mayle, V. Field, J. Holden, C. Sortwell, S. Fleming (Rootstown, USA)

    Objective: To investigate the role of corticostriatal synucleinopathy on behavioral function in an alpha-synuclein preformed fibril (a-Syn PFF) rat model of Parkinson’s disease (PD). Background:…
  • 2025 International Congress

    The Role of Depression and Anxiety in the Progression of Parkinson’s Disease

    N. Dahodwala, C. Hurley, T. Kapogiannis, H. Cho, C. Caspell-Garcia, D. Weintraub, R. Dobkin (Philadelphia, USA)

    Objective: To determine the association of depression and anxiety, and their treatment, with patient-reported outcomes (PROs) in a large, online, observational cohort of people with…
  • 2025 International Congress

    Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

    A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)

    Objective: To compare the allele frequencies of genetic variants associated with cognitive impairment between Parkinson's Disease (PD) patients and controls and to examine their interaction…
  • 2025 International Congress

    Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

    A. Sarwar, P. Bigner (Houston, USA)

    Objective: To compare certain key demographic features and QTc intervals in groups of PD military Veterans with and without psychosis. Background: Psychosis is a disabling…
  • 2025 International Congress

    Accuracy of the Tanner’s Questionnaire and the REM Sleep Behavior Disorder Single-Question Screen as Screening Tools for Parkinson’s Disease in a Brazilian Cohort

    G. Bolner, G. Magalhães Pereira, N. Medeiros Soares, C. Cenci Sangali, D. Dos Santos, T. de Carvalho, C. Mello Rieder, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: Assess the Tanner’s Questionnaire (TQ) and the REM Sleep Behavior Disorder Single-Question Screen (RBD1Q) performance as screening tools for Parkinson’s Disease (PD) in a…
  • 2025 International Congress

    Advancing MDS Guidelines for Electronic Clinical Outcome Assessments: Best Practices for Validation and Implementation

    R. Fuller, M. Skorvanek, M. Monje, M. Tosin, S. Ali, A. Lofald, A. Sanchez Ferro, T. Mestre (Princeton, USA)

    Objective: To update and formalize the International Parkinson and Movement Disorder Society (MDS) Clinical Outcomes Assessment Program guidelines on validating and evaluating electronic clinical outcome…
  • 2025 International Congress

    Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson’s disease

    R. Matsuyama, M. Nakamori, Y. Shimizu, O. Kikumoto, H. Maruyama (Hiroshima City, Japan)

    Objective: We investigated the swallowing sound index analyzed using an electronic stethoscope with artificial intelligence (AI) corresponds to the severity of Parkinson’s disease.(PD). Background: Several…
  • 2025 International Congress

    Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

    A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

    Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley